Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical Professionals Reference (MPR)
“We are encouraged by these interim results, which reinforce the potential of our hormone-free contraceptive candidate to provide women with a meaningful alternative to existing hormonal and non-hormonal methods.”
Family Medicine/General Practice July 30th 2025
British Medical Journal (The BMJ)
Among 8,391 women requiring meningioma surgery, prolonged desogestrel use showed location-specific risk patterns consistent with hormone-induced tumors, primarily affecting skull base regions.
Endocrinology, Diabetes, Metabolism July 1st 2025
Updated recommendations emphasize same-day contraceptive provision with minimal examination requirements, focusing on adolescent-centered counseling that addresses individual reproductive health goals across pediatric and gynecologic practice settings.
Adolescent Medicine July 1st 2025
This innovative intrauterine device may allow for improvements in discontinuation rates due to pain and bleeding and in expulsion rates.
Obstetrics & Gynecology March 12th 2025
Journal of the National Cancer Institute (JNCI)
A comprehensive analysis of 176,601 cancer cases demonstrates that long-acting reversible contraceptives offer a cancer risk profile comparable to oral contraceptives, with data showing a 20-30% reduction in gynecologic cancer risk and a modest increase in breast cancer risk that returns to baseline after cessation.
Obstetrics & Gynecology February 20th 2025
The court held that damages can extend to the long-term care of the child with special needs.
Obstetrics & Gynecology February 11th 2025